HAIR Restoration Robotics Inc

Restoration Roboticsâ„¢ to Hold Second Continuing Education Master Class for the ARTASâ„¢ Robotic Hair Restoration System

Restoration Robotics™ to Hold Second Continuing Education Master Class for the ARTAS™ Robotic Hair Restoration System

To be led by prominent hair restoration surgeon, Dr. Bessam Farjo in Manchester, UK

SAN JOSE, Calif., June 26, 2018 (GLOBE NEWSWIRE) -- Restoration Robotics, Inc. (NASDAQ:HAIR), a global leader in robotic hair restoration, today announced the second class in its continuing education Master Class Series for the ARTAS™ Robotic Hair Restoration System. The Master Class Series enables physicians to provide exceptional results to male aesthetic patients. The ARTAS Hair Transplant System is the first and only robotic system in the world designed to aid surgeons in hair restoration procedures.

This Master Class will be a two-day seminar led by Dr. Bessam Farjo on June 29th and 30th, and will consist of live surgery demonstrations, hands-on training and relevant lecture discussions. Dr. Farjo is Founding Director and Lead Hair Restoration Surgeon at the Farjo Hair Institute, one of the UK’s most revered brands in hair transplant surgery. He is well known for his innovative work in the field of hair restoration and his contributions in the development of the ARTAS Robotic System.

Ryan Rhodes, President and Chief Executive Officer of Restoration Robotics, said, “We are excited to announce the second event in our Master Class Series and continue to receive positive feedback from the attendees of our first session. We are confident that this ongoing series will not only help physicians to best achieve the aesthetic results desired by their patients, but also assist in driving physician demand for our advanced hair restoration technology.”

Dr. Farjo commented, “Leading the second Master Class on Robotic Hair Transplantation with Restoration Robotics is a great opportunity to educate other physicians on the resounding benefits of the ARTAS system. As new ARTAS Robotic Hair Restoration surgeons further develop their technical knowledge and skills using the system, I believe that interest in the procedure will continue to proliferate amongst my aesthetic-focused peers. I look forward to continuing to work with Restoration Robotics and to educate more physicians on ARTAS techniques and best practices.”

About Restoration Robotics

Restoration Robotics, Inc., is a medical device company developing and commercializing the ARTAS Robotic Hair Restoration System. We believe the ARTAS System is the first and only physician-assisted system to dissect, and assist in the harvesting of, follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. The Company has unique expertise in machine vision, image guidance, visual serving and robotics, as well as developing intuitive interfaces to manage these technologies.

   
Media Contact Investor Contact
Lisa Markle The Ruth Group
Director of Marketing Lee Roth & Brian Johnston
Restoration Robotics, Inc. +1 (646) 536-7000
+1 (408) 883-6764 
  
EN
26/06/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Restoration Robotics Inc

 PRESS RELEASE

Venus Concept Announces Fourth Quarter and Fiscal Year 2019 Financial ...

Venus Concept Announces Fourth Quarter and Fiscal Year 2019 Financial Results; Provides Preliminary First Quarter of 2020 Revenue Results and Updates Fiscal Year 2020 Revenue Guidance TORONTO, March 30, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months and twelve months ended December 31, 2019 and preliminary revenue results for the three months ending March 31, 2020. The Company notes that the financial results provided for the three months and twelv...

 PRESS RELEASE

Venus Concept Inc. Announces $22.25 Million Equity Financing

Venus Concept Inc. Announces $22.25 Million Equity Financing TORONTO, March 18, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it entered into a definitive agreement for the sale of shares of its common stock, Series A convertible preferred stock and warrants to purchase common stock in a private placement to a group of investors, including EW Healthcare Partners, HealthQuest Capital and SEDCO Capital. The private placement is expected to result in gross proceeds to the Compa...

 PRESS RELEASE

Venus Concept to Release Fourth Quarter and Fiscal Year 2019 Financial...

Venus Concept to Release Fourth Quarter and Fiscal Year 2019 Financial Results on March 30, 2020 TORONTO, March 10, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that fourth quarter and fiscal year 2019 financial results will be released after the market closes on Monday, March 30. Management will host a conference call at 5:00 p.m. Eastern Time on March 30 to discuss the results of the quarter and the year with a question and answer session. Those who would like to participate may di...

 PRESS RELEASE

Venus Concept Expands Executive Team

Venus Concept Expands Executive Team Chad A. Zaring, Appointed Chief Commercial Officer TORONTO, March 03, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that it has expanded its Executive Team with the appointment of Chad A. Zaring to the newly-created role of Chief Commercial Officer (“CCO”), effective February 10, 2020. Mr. Zaring has extensive experience in building and executing commercial strategies and driving sales for leading surgical robotics companies in his career. “We ar...

 PRESS RELEASE

Venus Concept Inc. Announces New Regulatory Clearances

Venus Concept Inc. Announces New Regulatory Clearances CE Mark Approval for Venus Bliss™️ for Non-Invasive Lipolysis of Abdomen & Flanks, Skin Tightening, Circumferential Reduction and Cellulite ReductionHealth Canada License to Market NeoGraft 2.0 for hair restoration TORONTO, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received CE Mark approval to market Venus Bliss for non-invasive lipolysis of the abdomen and flanks, skin tightening, circumferential re...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch